AB-1001

AB-1001 is an experimental gene therapy developed for Huntington's disease. It is intended to increase the production of the CYP46A1 enzyme and cholesterol levels in the brain.[1][2]

References

  1. ^ Parkin, Georgia M.; Corey-Bloom, Jody (2023). "Considerations and Advances in Huntington's Disease Clinical Trial Design". Biomarkers for Huntington's Disease: Improving Clinical Outcomes. Springer International Publishing. pp. 405–431. doi:10.1007/978-3-031-32815-2_17. ISBN 978-3-031-32815-2.
  2. ^ Schultz, Meredith; Durr, Alexandra; Karachi, Carine; O’Callaghan, Michael; Alves, Sandro; Lamontagne, Alain; Hurmic, Hortense; Cartier, Nathalie (25 April 2023). "Investigating the Effects of Brain Cholesterol Metabolism Using CYP46A1 Gene Therapy in Subjects with Huntington's Disease (P1-11.016)". Neurology. 100 (17 Supplement 2). doi:10.1212/WNL.0000000000203493. ISSN 0028-3878. S2CID 258404880.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.